D. King

发表

Heterogeneity of Prostate-Specific Membrane Antigen (PSMA) Expression in Prostate Carcinoma with Distant Metastasis

Slave Trajanoski, S. Mannweiler, J. Terrett, 2009, Pathology & Oncology Research.

Pharmacokinetics and immune response of 131I-chimeric mouse/human B72.3 (human gamma 4) monoclonal antibody in humans.

J. Schlom, R. Meredith, R. Wheeler, 1991, Cancer research.

A nonfucosylated human antibody to CD19 with potent B-cell depletive activity for therapy of B-cell malignancies

D. Blanset, D. King, Jie Liu, 2010, Cancer Immunology and Immunotherapy.

In vitro and In vivo Characterization of MDX-1401 for Therapy of Malignant Lymphoma

M. Srinivasan, R. Graziano, D. King, 2009, Clinical Cancer Research.

Antigen-specific activity of carcinoma-reactive BR64-doxorubicin conjugates evaluated in vitro and in human tumor xenograft models.

P. Trail, D. King, M. Zoeckler, 1992, Cancer research.

Spontaneous and estrogen-produced tumors in Nb rats and their behavior after transplantation.

R. Noble, D. King, B. C. Hochachka, 1975, Cancer research.

Binding to CD20 by Anti-B1 Antibody or F(ab')2 is sufficient for induction of apoptosis in B-cell lines

Yuni Fang, D. Colcher, D. King, 2002, Cancer Immunology, Immunotherapy.

Generation and Characterization of a Recombinant/Chimeric B72.3 (Human γ1)

P. Hand, J. Schlom, R. Callahan, 1991 .

CD10 is a key enzyme involved in the activation of tumor-activated peptide prodrug CPI-0004Na and novel analogues: implications for the design of novel peptide prodrugs for the therapy of CD10+ tumors.

Yi-hong Wang, D. King, G. Yarranton, 2003, Cancer research.

Binding to CD 20 by Anti-B 1 Antibody or F ( ab ’ ) 2 is sufficient for induction of apoptosis in B-cell lines

Yuni Fang, D. Colcher, D. King, 2022 .

Cytoplasmic and/or nuclear accumulation of the β‐catenin protein is a frequent event in human osteosarcoma

A. Montag, Hongwei Cheng, T. He, 2002, International journal of cancer.

Characterization and biodistribution of recombinant and recombinant/chimeric constructs of monoclonal antibody B72.3.

J. Schlom, M. Roselli, M. Bodmer, 1989, Cancer research.

Novel Biological Functions Associated with Epstein-Barr Virus DNA

B. Griffin, D. King, L. Karran, 1985 .

CD 10 Is a Key Enzyme Involved in the Activation of Tumor-activated Peptide Prodrug CPI-0004 Na and Novel Analogues : Implications for the Design of Novel Peptide Prodrugs for the Therapy of CD 10 Tumors

Yi-hong Wang, D. King, G. Yarranton, 2003 .

Single, low dose treatment of lymphoma and renal cancer xenografts with human anti-CD70 antibody-toxin conjugates, results in long term cures

J. Terrett, D. King, P. Cardarelli, 2007 .

Human antibody conjugates of potential utility for prostate cancer therapy: A comparison of MGBA conjugates with antibodies targeting a cell surface target (prostate-specific membrane antigen) and an extracellular matrix target (Mindin/RG-1)

J. Terrett, D. King, P. Cardarelli, 2008 .

Ptk7 as a direct and tumor stroma target in multiple solid malignancies

J. Terrett, D. King, Haichun Huang, 2008 .

Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells.

I. Bernstein, I. Bernstein, J. Eary, 1996, Cancer research.

In vitro and In vivo Characterization of MDX-1401 for Therapy of Malignant Lymphoma

M. Srinivasan, R. Graziano, D. King, 2009, Clinical Cancer Research.